Active Chest Tube Clearance Versus Standard Drainage After Cardiac Surgery
CLEAR-CS Stu
1 other identifier
observational
250
1 country
3
Brief Summary
Title: CLEAR-CS Study - Active Chest Tube Clearance After Cardiac Surgery This study looks at two methods of removing blood and fluid from the chest after heart surgery. After cardiac operations, patients usually have chest tubes placed to drain blood and fluid. Sometimes these tubes get blocked, leading to retained blood inside the chest. This can cause complications such as the need for another surgery, heart compression, or longer hospital stays. The study compares patients who received active chest tube clearance, a method designed to keep the tubes open and remove blood continuously, with patients who received standard passive chest tube drainage. Researchers will review medical records from three heart surgery centers to see which method is associated with fewer complications, less bleeding, and shorter hospital stays. No additional procedures will be performed as part of this study. Purpose: To evaluate whether active chest tube clearance improves safety and outcomes after heart surgery compared to standard drainage. Who Can Participate: This study uses data from adult patients (18 years and older) who underwent heart surgery with chest tubes placed. No new patients will be enrolled. Duration of Participation: Data from the period 2022-2024 will be analyzed. Risks and Benefits: There is no direct risk to patients, as no new procedures are being performed. The study may help improve chest drainage practices and reduce complications for future patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2022
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedFirst Submitted
Initial submission to the registry
March 17, 2026
CompletedFirst Posted
Study publicly available on registry
April 1, 2026
CompletedApril 1, 2026
March 1, 2026
3 years
March 17, 2026
March 29, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of Retained Blood Syndrome (RBS) after cardiac surgery
Composite outcome including reoperation for bleeding, cardiac tamponade requiring procedural intervention, hemothorax requiring additional drainage, or retained intrathoracic clot requiring procedural management. Data will be collected retrospectively from patient medical records.
"From end of surgery until hospital discharge or up to 30 days postoperatively, whichever occurs first, assessed by review of patient medical records by trained research personnel"
Secondary Outcomes (8)
Reoperation for bleeding
"From end of surgery until hospital discharge or up to 30 days postoperatively, whichever occurs first, assessed by review of patient medical records by trained research personnel"
Incidence of cardiac tamponade requiring procedural intervention
"From end of surgery until hospital discharge or up to 30 days postoperatively, whichever occurs first, assessed by review of patient medical records by trained research personnel"
Incidence of hemothorax requiring additional drainage
"From end of surgery until hospital discharge or up to 30 days postoperatively, whichever occurs first, assessed by review of patient medical records by trained research personnel"
Incidence of chest tube occlusion
"From end of surgery until hospital discharge or up to 30 days postoperatively, whichever occurs first, assessed by review of patient medical records by trained research personnel"
Incidence of postoperative atrial fibrillation
"From end of surgery until hospital discharge or up to 30 days postoperatively, whichever occurs first, assessed by review of patient medical records by trained research personnel"
- +3 more secondary outcomes
Study Arms (2)
Active Chest Tube Clearance
Patients managed with active chest tube clearance techniques intended to maintain chest tube patency and facilitate continuous evacuation of postoperative blood. No additional interventions are applied beyond standard care.
Standard Passive Chest Tube Drainage
Patients managed with standard passive chest tube drainage following cardiac surgery. No additional interventions are applied beyond standard care.
Eligibility Criteria
Adult patients who underwent cardiac surgery with mediastinal chest tube placement at participating tertiary cardiac surgery centers. Data will be collected retrospectively from medical records; no direct patient contact occurs.
You may qualify if:
- Adult patients (≥18 years) undergoing cardiac surgery via median sternotomy, including CABG, valve surgery, or combined procedures.
- Placement of mediastinal chest tubes postoperatively
You may not qualify if:
- Redo sternotomy
- Surgery for acute aortic dissection
- Heart transplantation
- Mechanical circulatory support implantation
- Incomplete or missing essential medical records
- Intraoperative death
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Assiut University Faculty of Medicine
Asyut, Egypt
Beni Suef University Faculty of Medicine
Banī Suwayf, Egypt
Cairo University Hospital
Cairo, 02, Egypt
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate proffessor
Study Record Dates
First Submitted
March 17, 2026
First Posted
April 1, 2026
Study Start
January 1, 2022
Primary Completion
December 30, 2024
Study Completion
December 30, 2024
Last Updated
April 1, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared with other researchers. The study involves retrospective analysis of de-identified patient data collected from institutional medical records. Data sharing is restricted due to institutional policies and confidentiality considerations.